• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 4. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Cyclohexanols
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Study of 3,4-Dimethylcyclohexan-1-ol (CAS: 5715-23-1) in Chemical Biology and Pharmaceutical Research

The compound 3,4-dimethylcyclohexan-1-ol (CAS: 5715-23-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential industrial applications. The information presented herein is derived from peer-reviewed academic literature, industry reports, and technical documents published within the last two years.

Recent studies have highlighted the role of 3,4-dimethylcyclohexan-1-ol as a versatile intermediate in the synthesis of complex organic molecules. Its cyclohexane backbone, substituted with methyl groups at the 3 and 4 positions, provides a rigid yet flexible framework that can be functionalized for various applications. Researchers have explored its use in the development of novel chiral ligands for asymmetric catalysis, as well as its potential as a building block for pharmaceuticals targeting neurological disorders. The compound's stereochemistry has been a particular focus, with investigations into how different enantiomers exhibit distinct biological activities.

In the realm of pharmaceutical research, 3,4-dimethylcyclohexan-1-ol has shown promise as a precursor for the synthesis of bioactive molecules. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in creating analogs of known GABA receptor modulators, with several derivatives exhibiting enhanced binding affinity and selectivity. The research team employed computational modeling and X-ray crystallography to elucidate the structure-activity relationships, providing valuable insights for future drug design efforts.

From a synthetic chemistry perspective, advancements have been made in the efficient production of 3,4-dimethylcyclohexan-1-ol. A novel catalytic hydrogenation method developed by researchers at ETH Zurich has improved the yield and enantiomeric purity of the compound, addressing previous challenges in large-scale production. This breakthrough, published in Angewandte Chemie, utilizes a chiral ruthenium catalyst system that achieves up to 98% enantiomeric excess, making it particularly valuable for pharmaceutical applications where stereochemical purity is crucial.

The compound's physicochemical properties have also been the subject of recent investigations. Studies examining its solubility profile, partition coefficients, and stability under various conditions have provided essential data for formulation scientists. These characteristics make 3,4-dimethylcyclohexan-1-ol particularly interesting for drug delivery applications, where its amphiphilic nature could be exploited to improve the bioavailability of poorly soluble active pharmaceutical ingredients.

Looking forward, researchers anticipate that 3,4-dimethylcyclohexan-1-ol will play an increasingly important role in the development of new therapeutic agents and specialty chemicals. Its structural features make it a valuable scaffold for medicinal chemistry, while its synthetic accessibility positions it as an attractive intermediate for industrial applications. Ongoing research is exploring its potential in areas ranging from antimicrobial agents to materials science, suggesting that the full scope of its applications has yet to be realized.

• 140145-83-1((2S)-1-cyclohexylpropan-2-ol)
• 50538-78-8((1S,3S)-3-methylcyclohexan-1-ol)
• 10488-12-7(Cyclohexanol, 3-(1-methylethyl)-, cis-)
• 10488-21-8(Cyclohexanol, 3-(1-methylethyl)-, trans-)
• 20178-33-0(Cyclohexanol, 4,4'-methylenebis-)
• 24965-92-2((1S,3R)-3-methylcyclohexan-1-ol)
• 106349-22-8([1,1'-Bicyclohexyl]-4-ol, 2'-methyl-4'-propyl-)
• 80407-01-8(4-Hexylcyclohexan-1-ol)
• 502157-42-8(Cyclohexanol, 4-[2-(trans-4-pentylcyclohexyl)ethyl]-)
• 830322-14-0(Cyclohexanol, 4-(3-methylbutyl)-)